NASDAQ$SRTA
Strata Critical Medical Inc · Q2 2025 earnings
Q2 2025 earnings · · Before market open · Investor relations
Briefing
Blade Air Mobility reported Q2 2025 revenue of $70.8 million and a net loss of $3.7 million.
The company posted revenue growth of 4.2% year-over-year to $70.8 million for the three months ended June 30, 2025. The Medical segment drove the increase with 17.6% growth while the Passenger segment declined 13.2%. Net loss narrowed significantly to $3.7 million from $11.3 million in the prior year quarter.
- Q2 revenue reached $70.8 million, up 4.2% from $67.9 million in Q2 2024.
- Medical segment revenue grew 17.6% to $45.1 million while Passenger fell 13.2% to $25.7 million.
- Net loss improved to $3.7 million from $11.3 million year-over-year.
- Adjusted EBITDA rose to $3.2 million from $1.0 million in the prior year quarter.
Headline financials
Revenue & EPS history
Strata Critical Medical · Revenue · Quarterly
$70.8M
Revenue by segment
Strata Critical Medical · $70.8M total across 2 segments · Q2 2025
- Medical$45.1M—63.7%
- Passenger$25.7M—36.3%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports
+3.4%
Avg return
Earnings day
+2.8%
Avg return
5 days after
+5.7%
Avg return
30 days after
54%
13 / 24 earnings
Positive
+38.8%
Q3 2023
Best reaction
-32.1%
Q4 2023
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q2 2025 | — | — | — | |
| Q1 2026 | +10.6% | +17.2% | +19.7% | |
| Q4 2025 | +6.9% | +1.1% | -7.6% | |
| Q3 2025 | +9.5% | +8.1% | +4.3% | |
| Q1 2025 | +18.7% | +20.5% | +41.4% | |
| Q4 2024 | +7.1% | +8.1% | -4.9% | |
| Q3 2024 | -4.4% | -17.5% | +8.9% | |
| Q2 2024 | +17.3% | +3.6% | +2.9% | |
| Q1 2024 | -3.3% | -3.3% | -16.0% | |
| Q4 2023 | -32.1% | -32.3% | -3.5% | |
| Q3 2023 | +38.8% | +44.5% | +44.5% | |
| Q2 2023 | -7.9% | -6.7% | -24.3% | |
| Q1 2023 | +9.4% | +2.8% | +28.1% | |
| Q4 2022 | -9.7% | -22.3% | -32.0% | |
| Q3 2022 | -2.3% | -0.2% | +3.4% | |
| Q2 2022 | +8.0% | +6.9% | -17.5% | |
| Q1 2022 | -15.0% | +0.9% | -2.3% | |
| Q4 2021 | -3.2% | +5.2% | -2.0% | |
| Q3 2021 | +0.3% | +2.1% | +41.4% | |
| Q2 2021 | +18.0% | +16.4% | +58.7% | |
| Q1 2021 | +13.7% | +11.8% | -11.8% | |
| Q4 2020 | -0.1% | -0.1% | +3.1% | |
| Q2 2020 | +0.0% | -0.2% | -0.1% | |
| Q1 2020 | +1.0% | +1.0% | +1.3% | |
| Q4 2019 | -0.2% | -0.3% | +0.7% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro